In this episode, we explore the significant clinical milestone achieved by Experience Ibogaine, which reports a 99% success rate during the detoxification phase of its ibogaine treatment protocols. Based in Tijuana, Mexico, the center emphasizes that while this high success rate facilitates effective physical stabilization from acute withdrawal, it represents only the initial stage of recovery. Aeden Smith-Ahearn, founder of Experience Ibogaine, highlights a critical industry distinction: medically supervised ibogaine detox provides a necessary window for healing, but it is not a standalone cure for addiction. The discussion underscores the vital importance of rigorous patient screening, including comprehensive liver function testing and medical history reviews, to ensure safety and eligibility. By framing detox as the first step rather than the final destination, the center advocates for a balanced perspective on addiction treatment. This episode examines the implications of integrating safe, medically supervised ibogaine sessions with long-term behavioral support and honest self-assessment. Listeners gain insight into how professional, clinical oversight shapes successful outcomes and why realistic expectations are foundational to sustained sobriety and effective patient care in the modern landscape of addiction medicine.

---
📰 Read the full press release
🌐 Visit https://www.experienceibogaine.com/